Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Zymeworks Inc
Zymeworks Inc logo

ZYME - Zymeworks Inc Reuters News

$48.37 -3.8  -7.3%

Last Trade - 25/01/21

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Momentum Trap
Market Cap £1.75bn
Enterprise Value £1.40bn
Revenue £18.4m
Position in Universe 1962nd / 6623
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions ZYME Dividends
Reuters News
All News Reuters News Company Announcements
BRIEF-Zymeworks Inc - Enrollment Continues For Zanidatamab Global Pivotal Trial In BTC Global Pivotal Trial In First-Line GEA Slated To Open In Mid-2021
15th Jan News
BRIEF-Zymeworks Files Prospectus Supplement Registers For Resale, From Time To Time, Up To 6.95 Mln Of Common Shares By Selling Shareholders
4th Dec '20 News
BRIEF-Exelixis In Licenses Iconic Therapeutics' Tissue Factor-Targeting Antibody-Drug Conjugate Ahead Of Planned Investigational New Drug Application
2nd Dec '20 News
BUZZ-U.S. STOCKS ON THE MOVE-J&J, Mogo, BridgeBio Pharma, Sandridge Energy
1st Dec '20 News
BUZZ-U.S. STOCKS ON THE MOVE-CSX Corp, Square, Delta Air, Suncor, BlackBerry
1st Dec '20 News
BRIEF-Zymeworks Announces Expansion of Zanidatamab Pivotal Trial in HER2-Amplified Biliary Tract Cancer in Asia in Collaboration With BeiGene
1st Dec '20 News
BUZZ-Zymeworks: Guggenheim bets on breast cancer drug candidates, raises PT
1st Dec '20 News
BRIEF-Zymeworks Receives FDA Breakthrough Therapy Designation For HER2-Targeted Bispecific Antibody Zanidatamab In Patients With Biliary Tract Cancer
30th Nov '20 News
BRIEF-Zymeworks And Alx Oncology Announce Clinical Collaboration Evaluating Zanidatamab With The Cd47 Blocker Alx148
16th Nov '20 News
BUZZ-U.S. STOCKS ON THE MOVE-Uber, Alibaba, solar energy stocks, big tech
4th Nov '20 News
BRIEF-Zymeworks Reports Q3 Rev Of $2.6 Mln
3rd Nov '20 News
BRIEF-ImmunoPrecise Announces New Multi-Specific SARS-CoV-2 Antibody Collaboration With Zymeworks
17th Sep '20 News
BRIEF-Zymeworks Reports Qtrly Loss Per Share $0.77
5th Aug '20 News
BRIEF-Zymeworks & Merck Sign New License Agreement
8th Jul '20 News
BRIEF-Zymeworks Posts Quarterly Loss Per Share Of $0.64
7th May '20 News
BRIEF-Zymeworks Announces First Patient Dosed In Phase 1B/2 Trial Of Zw25 In First-Line Her2-Positive Breast Cancer And Gastroesophageal Adenocarcinoma Conducted By Beigene
1st Apr '20 News
BUZZ-Biotech Zymeworks slips from record highs after upsized stock offering
23rd Jan '20 News
BRIEF-Zymeworks Announces Pricing Of Public Offering Of 4.9 Mln Common Shares At Price To Public Of US$46.50 Per Share
23rd Jan '20 News
BRIEF-Zymeworks Files Preliminary Prospectus Supplements For Offering Of Common Shares And Pre-Funded Warrants
21st Jan '20 News
BRIEF-Zymeworks Announces Agreement With Pfizer
12th Jan '20 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.